Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

AACR 2012 /
Anti-angiogenic agents and cancer stem cells

31st Mar - 4th Apr 2012

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 13.04.12
Views: 4553
Rating:

Dr Max Wicha - University of Michigan, Ann Arbor, USA

Dr Max Wicha talks about the session he chaired at the AACR 2012 Annual Meeting on clinical implications of cancer stem cells and large number of trials underway examining these cells.

 

He also highlights two examples; the effects of anti-angiogenic agents on cancer stem cells and role of HER 2 in driving cancer stem cells in human breast cancer.

Previous conferences: highlights



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation